Article
Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system.
Virus research - 1 Apr 2011
Mori Kyoko, Ikeda Masanori, Ariumi Yasuo, Dansako Hiromichi, Wakita Takaji, Kato Nobuyuki
Abstract excerpt
Ribavirin (RBV) is a potential partner of interferon (IFN)-based therapy for patients with chronic hepatitis C. However, to date, its anti-hepatitis C virus (HCV) mechanism remains ambiguous due to the marginal activity of RBV on HCV RNA replication in HuH-7-derived cells, which are currently used as the only cell culture system for robust HCV replication. We investigated the anti-HCV activity of RBV using novel...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
